XML 61 R38.htm IDEA: XBRL DOCUMENT v3.22.4

Investment in Associate (Tables)

12 Months Ended

Dec. 31, 2022

VISEN Pharmaceuticals [member]

Disclosure of associates [line items]

Schedule of Financial Information of Investment in VISEN

The following table illustrates the summarized relevant financial information of VISEN:

		VISEN Pharmaceuticals
Principal place of business		China
		2022				2021
		(EUR’000)
Statement of profit or loss
Profit/(loss) for the year from continuing operations			(40,283	)			(69,283	)
Total comprehensive income			(40,273	)			(69,306	)
Statement of financial position
Non-current assets			21,410				16,599
Current assets			92,204				130,825
Total assets			113,614				147,424
Equity			100,062				135,333
Non-current liabilities			180				1,545
Current liabilities			13,372				10,546
Total equity and liabilities			113,614				147,424
Company’s share of equity before eliminations			43,957				59,455
Elimination of internal profit and other equity method adjustments			(21,025	)			(21,110	)
Company’s share of equity			22,932				38,345
Investment in associate at December 31			22,932				38,345
Present ownership at December 31			43.93	%			43.93	%
Transactions and outstanding balances as of December 31
Invoicing of goods and services to associate			22,327				6,472
Trade receivables from associate			3,554				1,644

X

- Definition

The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_SignificantInvestmentsInAssociatesAxis=asnd_VISENPharmaceuticalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: